Thermo Fisher Scientific INC (TMO) Holder Schwab Charles Investment Management INC Trimmed Its Holding

April 17, 2018 - By Linda Rogers

Thermo Fisher Scientific Inc. (NYSE:TMO) LogoInvestors sentiment decreased to 0.91 in Q4 2017. Its down 0.05, from 0.96 in 2017Q3. It dived, as 43 investors sold TMO shares while 410 reduced holdings. 93 funds opened positions while 319 raised stakes. 335.65 million shares or 0.74% more from 333.20 million shares in 2017Q3 were reported. Covington Inv Advsrs stated it has 0.92% in Thermo Fisher Scientific Inc. (NYSE:TMO). Highland Cap Mgmt Ltd accumulated 0.56% or 38,746 shares. Commonwealth Commercial Bank Of Aus owns 0.05% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 24,525 shares. Mutual Of America Management Lc has invested 0.15% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Oppenheimer has invested 0.41% in Thermo Fisher Scientific Inc. (NYSE:TMO). Raymond James Ser invested in 0.05% or 40,784 shares. Highlander Cap Management Limited Liability Corp has 0.03% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). 1,200 were accumulated by Balyasny Asset Management Limited Liability Corp. Girard Ptnrs holds 19,756 shares or 0.72% of its portfolio. Wealth Architects Limited Liability Corp reported 1,377 shares. Moreover, Associated Banc has 0.25% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 24,232 shares. Cape Cod Five Cents Bank & Trust has invested 0.04% in Thermo Fisher Scientific Inc. (NYSE:TMO). Tower Bridge has invested 0.5% in Thermo Fisher Scientific Inc. (NYSE:TMO). Ngam Advsrs Ltd Partnership reported 159,127 shares stake. Cullinan Associates invested 0.3% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO).

Since December 15, 2017, it had 0 buys, and 8 selling transactions for $37.14 million activity. 80,000 shares were sold by CASPER MARC N, worth $16.94M on Wednesday, March 21. Herrema Gregory J. sold $7.32 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Friday, February 2. Williamson Stephen sold $1.05 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday, February 7. Durbin Patrick M also sold $1.31 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Monday, February 5.

Schwab Charles Investment Management Inc decreased its stake in Thermo Fisher Scientific Inc (TMO) by 2.68% based on its latest 2017Q4 regulatory filing with the SEC. Schwab Charles Investment Management Inc sold 42,085 shares as the company’s stock rose 8.51% while stock markets declined. The institutional investor held 1.53M shares of the industrial machinery and components company at the end of 2017Q4, valued at $290.27M, down from 1.57 million at the end of the previous reported quarter. Schwab Charles Investment Management Inc who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be less bullish one the $87.56B market cap company. The stock increased 0.80% or $1.7256 during the last trading session, reaching $217.6356. About 303,859 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 33.66% since April 17, 2017 and is uptrending. It has outperformed by 22.11% the S&P500.

Schwab Charles Investment Management Inc, which manages about $126.11B US Long portfolio, upped its stake in Jpmorgan Chase & Co (NYSE:JPM) by 373,921 shares to 12.69M shares, valued at $1.36 billion in 2017Q4, according to the filing. It also increased its holding in Exelon Corp (NYSE:EXC) by 119,590 shares in the quarter, for a total of 3.83M shares, and has risen its stake in Ryder Sys Inc (NYSE:R).

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on April, 25. They expect $2.40 earnings per share, up 15.38 % or $0.32 from last year’s $2.08 per share. TMO’s profit will be $965.57M for 22.67 P/E if the $2.40 EPS becomes a reality. After $2.79 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -13.98 % negative EPS growth.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 10 analysts covering Thermo Fisher (NYSE:TMO), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Thermo Fisher has $250 highest and $200.0 lowest target. $231.20’s average target is 6.23% above currents $217.6356 stock price. Thermo Fisher had 16 analyst reports since October 20, 2017 according to SRatingsIntel. The company was maintained on Monday, December 4 by Leerink Swann. The firm earned “Buy” rating on Monday, October 23 by Robert W. Baird. The firm has “Overweight” rating given on Thursday, February 1 by Barclays Capital. The firm has “Hold” rating by Jefferies given on Friday, October 20. Jefferies maintained the shares of TMO in report on Thursday, February 1 with “Hold” rating. Deutsche Bank maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Thursday, October 26. Deutsche Bank has “Buy” rating and $226 target. The rating was maintained by Leerink Swann on Thursday, February 1 with “Buy”. As per Wednesday, January 31, the company rating was maintained by Cowen & Co. As per Wednesday, January 31, the company rating was maintained by Robert W. Baird. The firm earned “Buy” rating on Wednesday, October 25 by Cowen & Co.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: